Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
51 hedge funds and large institutions have $258M invested in Loxo Oncology, Inc in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
2% more funds holding
Funds holding: 50 → 51 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $260M → $258M (-$2.47M)
18% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$6.98M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.51M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$1.87M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$1.58M |
| 5 |
Axa
Paris,
France
|
+$1.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$7.08M |
| 2 |
JP Morgan Chase
New York
|
-$2.99M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$1.64M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.43M |
| 5 |
Millennium Management
New York
|
-$847K |
LOXO Hedge Fund Activity: Q3 2015 in Review
51 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q3 2015, worth a combined $258M — down 0.95% from $260M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new LOXO positions and 4 closed out — a net gain of 2 holders — while 14 added to existing stakes and 17 trimmed.
The largest buyer was RS Investment Management, adding an estimated $6.98M. The largest seller was Deerfield Management, cutting an estimated $7.08M.
- 51 institutional investors held Loxo Oncology, Inc (LOXO) as of Q3 2015, up from 50 in Q2 2015.
- Funds reported $258M of Loxo Oncology, Inc stock for Q3 2015, down 0.95% quarter-over-quarter.
- 6 funds opened new Loxo Oncology, Inc positions in Q3 2015 and 4 closed out, a net change of +2 holders.
- The largest Loxo Oncology, Inc buyer in Q3 2015 was RS Investment Management, an estimated $6.98M added.
- The largest Loxo Oncology, Inc seller in Q3 2015 was Deerfield Management, an estimated $7.08M sold.
Based on aggregated 13F filings for Q3 2015.